Building the
Definitive Peptide
Reference
Axiom Peptides is a curated, evidence-first education platform documenting the bioactive peptides that are reshaping how we think about wellness, recovery, and longevity research.
Bridging the gap
between bench
and bedside.
Most peptide information online is either fragmented across academic papers, oversimplified by wellness influencers, or buried behind paywalls. We exist to fix that.
Every peptide on this platform is documented with its mechanism, research status, benefits, safety profile, and source citations. No hype. No shortcuts.
We do not publish anything without a citation. When research is preliminary, we say so. When a peptide has FDA approval, we name the indication and the trial data. When a compound is only studied in animal models, that limitation is front and center.
For each peptide, we explain the receptor it binds, the cascade it triggers, and the downstream effects observed. This mechanistic understanding is what separates education from supplement marketing.
Preclinical research is not the same as Phase III trials. Russian clinical experience is not the same as FDA approval. We use precise language about regulatory and research status so readers can make informed decisions about what they're reading.
We do not sell peptides. We do not recommend protocols. We do not replace your physician. Every page on this site exists to inform research and conversations with qualified medical professionals.
The scope of
our reference library
Each profile covers mechanism, structure, benefits, research status, safety, and related compounds.
From body composition and healing to cognitive enhancement, anti-aging, and immune support.
Drawing on peer-reviewed literature from PubMed, ClinicalTrials.gov, and major research journals.
Including Tesamorelin, Bremelanotide, and Thymosin Alpha-1 with full regulatory context.
Including peptides approved or studied in Russia, Japan, the EU, and emerging markets.
New research summaries published as clinical data emerges. Last updated: June 2026.
Stay Informed on
Peptide Research
Research summaries, newly documented peptides, and clinical trial updates delivered to your inbox.
No spam. Unsubscribe at any time.